APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Crohn’s Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Crohn’s Disease Treatment Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchCrohn’s Disease Treatment Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Crohn’s Disease Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Crohn’s Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crohn’s Disease Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Crohn’s Disease Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Crohn’s Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Crohn’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Crohn’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crohn’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Crohn’s Disease Treatment market include Takeda Pharmaceutical Ltd, Johnson & Johnson, Roche, Pfizer Inc., Biogen, Bristol Myers Squibb, Abbvie Inc., AstraZeneca and Prometheus Laboratories Inc. (Nestle), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Crohn’s Disease Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Crohn’s Disease Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crohn’s Disease Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Crohn’s Disease Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Crohn’s Disease Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Crohn’s Disease Treatment Market by Company

Takeda Pharmaceutical Ltd

Johnson & Johnson

Roche

Pfizer Inc.

Biogen

Bristol Myers Squibb

Abbvie Inc.

AstraZeneca

Prometheus Laboratories Inc. (Nestle)

Bausch Health

Crohn’s Disease Treatment Segment by Type

Corticosteroids

Immunomodulators

Antibiotics

Amino Salicylates

Others

Crohn’s Disease Treatment Segment by Application

Hospitals

Specialty Clinics

Other

Crohn’s Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Crohn’s Disease Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Crohn’s Disease Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Crohn’s Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Crohn’s Disease Treatment Market Share by Region (2021-2026) Table 4. Global Crohn’s Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Crohn’s Disease Treatment Market Share by Region (2027-2032) Table 6. Global Crohn’s Disease Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Crohn’s Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Crohn’s Disease Treatment Market Size Share by Type (2021-2026) Table 9. Global Crohn’s Disease Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Crohn’s Disease Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Crohn’s Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Crohn’s Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Crohn’s Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Crohn’s Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Crohn’s Disease Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Crohn’s Disease Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Crohn’s Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Crohn’s Disease Treatment Market Size Share by Application (2021-2026) Table 24. Global Crohn’s Disease Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Crohn’s Disease Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Crohn’s Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Crohn’s Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Crohn’s Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Crohn’s Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Crohn’s Disease Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Crohn’s Disease Treatment Industry Trends Table 37. Crohn’s Disease Treatment Industry Drivers Table 38. Crohn’s Disease Treatment Industry Opportunities and Challenges Table 39. Crohn’s Disease Treatment Industry Restraints Table 40. Global Crohn’s Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Crohn’s Disease Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Crohn’s Disease Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Crohn’s Disease Treatment Key Company Headquarters & Area Served Table 44. Global Crohn’s Disease Treatment Company, Product Type & Application Table 45. Global Crohn’s Disease Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Crohn’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Ltd Company Information Table 49. Takeda Pharmaceutical Ltd Business Overview Table 50. Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Product Portfolio Table 52. Takeda Pharmaceutical Ltd Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Crohn’s Disease Treatment Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Roche Crohn’s Disease Treatment Product Portfolio Table 62. Roche Recent Development Table 63. Pfizer Inc. Company Information Table 64. Pfizer Inc. Business Overview Table 65. Pfizer Inc. Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Inc. Crohn’s Disease Treatment Product Portfolio Table 67. Pfizer Inc. Recent Development Table 68. Biogen Company Information Table 69. Biogen Business Overview Table 70. Biogen Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biogen Crohn’s Disease Treatment Product Portfolio Table 72. Biogen Recent Development Table 73. Bristol Myers Squibb Company Information Table 74. Bristol Myers Squibb Business Overview Table 75. Bristol Myers Squibb Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bristol Myers Squibb Crohn’s Disease Treatment Product Portfolio Table 77. Bristol Myers Squibb Recent Development Table 78. Abbvie Inc. Company Information Table 79. Abbvie Inc. Business Overview Table 80. Abbvie Inc. Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Abbvie Inc. Crohn’s Disease Treatment Product Portfolio Table 82. Abbvie Inc. Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AstraZeneca Crohn’s Disease Treatment Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Prometheus Laboratories Inc. (Nestle) Company Information Table 89. Prometheus Laboratories Inc. (Nestle) Business Overview Table 90. Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Product Portfolio Table 92. Prometheus Laboratories Inc. (Nestle) Recent Development Table 93. Bausch Health Company Information Table 94. Bausch Health Business Overview Table 95. Bausch Health Crohn’s Disease Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Bausch Health Crohn’s Disease Treatment Product Portfolio Table 97. Bausch Health Recent Development Table 98. North America Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Crohn’s Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Crohn’s Disease Treatment Market Share by Country (2021-2026) Table 101. North America Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Crohn’s Disease Treatment Market Share Forecast by Country (2027-2032) Table 103. Europe Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Crohn’s Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Crohn’s Disease Treatment Market Share by Country (2021-2026) Table 106. Europe Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Crohn’s Disease Treatment Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Crohn’s Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Crohn’s Disease Treatment Market Share by Country (2021-2026) Table 111. Asia-Pacific Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Crohn’s Disease Treatment Market Share Forecast by Country (2027-2032) Table 113. Latin America Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Crohn’s Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Crohn’s Disease Treatment Market Share by Country (2021-2026) Table 116. Latin America Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Crohn’s Disease Treatment Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Crohn’s Disease Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Crohn’s Disease Treatment Market Share by Country (2021-2026) Table 121. Middle East & Africa Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Crohn’s Disease Treatment Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Crohn’s Disease Treatment Product Image Figure 3. Global Crohn’s Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Crohn’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Crohn’s Disease Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Crohn’s Disease Treatment Market Share by Region (2021-2032) Figure 7. North America Crohn’s Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Crohn’s Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Crohn’s Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Crohn’s Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Crohn’s Disease Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Corticosteroids Image Figure 13. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Immunomodulators Image Figure 15. Global Immunomodulators Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Antibiotics Image Figure 17. Global Antibiotics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Amino Salicylates Image Figure 19. Global Amino Salicylates Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Crohn’s Disease Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Crohn’s Disease Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Crohn’s Disease Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Crohn’s Disease Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Crohn’s Disease Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Crohn’s Disease Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Crohn’s Disease Treatment Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Specialty Clinics Image Figure 32. Global Specialty Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Crohn’s Disease Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Crohn’s Disease Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Crohn’s Disease Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Crohn’s Disease Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Crohn’s Disease Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Crohn’s Disease Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Crohn’s Disease Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Crohn’s Disease Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Crohn’s Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Crohn’s Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Crohn’s Disease Treatment Market Share by Country (2021-2032) Figure 47. Europe Crohn’s Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Crohn’s Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Crohn’s Disease Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Crohn’s Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Crohn’s Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Crohn’s Disease Treatment Market Share by Country (2021-2032) Figure 53. Latin America Crohn’s Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Crohn’s Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Crohn’s Disease Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Crohn’s Disease Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Crohn’s Disease Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Crohn’s Disease Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Immunomodulators
  • Antibiotics
  • Amino Salicylates
  • Others
Applications
  • Hospitals
  • Specialty Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Ltd
  • Johnson & Johnson
  • Roche
  • Pfizer Inc.
  • Biogen
  • Bristol Myers Squibb
  • Abbvie Inc.
  • AstraZeneca
  • Prometheus Laboratories Inc. (Nestle)
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Crohn’s Disease Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Crohn’s Disease Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Crohn’s Disease Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Crohn’s Disease Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Crohn’s Disease Treatment Market Size (2021-2032)
  8. 1.5.1 North America Crohn’s Disease Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Crohn’s Disease Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Crohn’s Disease Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Crohn’s Disease Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Crohn’s Disease Treatment Market Size Growth Rate (2021-2032)
2 Crohn’s Disease Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Corticosteroids
  3. 2.1.2 Immunomodulators
  4. 2.1.3 Antibiotics
  5. 2.1.4 Amino Salicylates
  6. 2.1.5 Others
  7. 2.2 Global Crohn’s Disease Treatment Market Size by Type
  8. 2.2.1 Global Crohn’s Disease Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Crohn’s Disease Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Crohn’s Disease Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Crohn’s Disease Treatment Market Size by Regions
  12. 2.3.1 North America Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Crohn’s Disease Treatment Market Size Breakdown by Type (2021-2026)
3 Crohn’s Disease Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Specialty Clinics
  4. 3.1.3 Other
  5. 3.2 Global Crohn’s Disease Treatment Market Size by Application
  6. 3.2.1 Global Crohn’s Disease Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Crohn’s Disease Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Crohn’s Disease Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Crohn’s Disease Treatment Market Size by Regions
  10. 3.3.1 North America Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Crohn’s Disease Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Crohn’s Disease Treatment Industry Trends
  2. 4.2 Crohn’s Disease Treatment Industry Drivers
  3. 4.3 Crohn’s Disease Treatment Industry Opportunities and Challenges
  4. 4.4 Crohn’s Disease Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Crohn’s Disease Treatment Revenue (2021-2026)
  2. 5.2 Global Crohn’s Disease Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Crohn’s Disease Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Crohn’s Disease Treatment Company, Product Type & Application
  5. 5.5 Global Crohn’s Disease Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Crohn’s Disease Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Crohn’s Disease Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Crohn’s Disease Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Ltd
  2. 6.1.1 Takeda Pharmaceutical Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Ltd Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Crohn’s Disease Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Roche Crohn’s Disease Treatment Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc. Crohn’s Disease Treatment Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 Biogen
  26. 6.5.1 Biogen Company Information
  27. 6.5.2 Biogen Business Overview
  28. 6.5.3 Biogen Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biogen Crohn’s Disease Treatment Product Portfolio
  30. 6.5.5 Biogen Recent Developments
  31. 6.6 Bristol Myers Squibb
  32. 6.6.1 Bristol Myers Squibb Company Information
  33. 6.6.2 Bristol Myers Squibb Business Overview
  34. 6.6.3 Bristol Myers Squibb Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bristol Myers Squibb Crohn’s Disease Treatment Product Portfolio
  36. 6.6.5 Bristol Myers Squibb Recent Developments
  37. 6.7 Abbvie Inc.
  38. 6.7.1 Abbvie Inc. Company Information
  39. 6.7.2 Abbvie Inc. Business Overview
  40. 6.7.3 Abbvie Inc. Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Abbvie Inc. Crohn’s Disease Treatment Product Portfolio
  42. 6.7.5 Abbvie Inc. Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Crohn’s Disease Treatment Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Prometheus Laboratories Inc. (Nestle)
  50. 6.9.1 Prometheus Laboratories Inc. (Nestle) Company Information
  51. 6.9.2 Prometheus Laboratories Inc. (Nestle) Business Overview
  52. 6.9.3 Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Product Portfolio
  54. 6.9.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
  55. 6.10 Bausch Health
  56. 6.10.1 Bausch Health Company Information
  57. 6.10.2 Bausch Health Business Overview
  58. 6.10.3 Bausch Health Crohn’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Bausch Health Crohn’s Disease Treatment Product Portfolio
  60. 6.10.5 Bausch Health Recent Developments
7 North America
  1. 7.1 North America Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Crohn’s Disease Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Crohn’s Disease Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Crohn’s Disease Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Crohn’s Disease Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Crohn’s Disease Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Crohn’s Disease Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst